Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BZAD01 是一种选择性 NMDA NR1A/2B 受体拮抗剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 923 | 现货 | ||
5 mg | ¥ 2,470 | 现货 | ||
10 mg | ¥ 3,660 | 现货 | ||
25 mg | ¥ 5,890 | 现货 | ||
50 mg | ¥ 8,180 | 现货 | ||
100 mg | ¥ 10,800 | 现货 | ||
500 mg | ¥ 21,900 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,490 | 现货 |
产品描述 | BZAD01 is a selective NMDA NR1A/2B receptor antagonist. |
体内活性 | Parkinsonism was induced by microinjection of the toxin, 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB) of 40 Sprague-Dawley rats. Parkinsonism and the efficacy of drugs were assessed using a battery of behavioural tests including balance beam, apomorphine-induced rotation, body axis bias or "curling", head position bias and disengage sensorimotor latency test. The main effects were that BZAD01 co-administration prevented chronic levodopa-induced potentiation of apomorphine rotation. However levodopa-treated rats were slower than either controls or BZAD-01-treated rats in the locomotor test[2]. |
别名 | BZAD-01, BZAD 01 |
分子量 | 362.27 |
分子式 | C16H12F6N2O |
CAS No. | 305339-41-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (151.82 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.7604 mL | 13.8019 mL | 27.6037 mL | 69.0093 mL |
5 mM | 0.5521 mL | 2.7604 mL | 5.5207 mL | 13.8019 mL | |
10 mM | 0.276 mL | 1.3802 mL | 2.7604 mL | 6.9009 mL | |
20 mM | 0.138 mL | 0.6901 mL | 1.3802 mL | 3.4505 mL | |
50 mM | 0.0552 mL | 0.276 mL | 0.5521 mL | 1.3802 mL | |
100 mM | 0.0276 mL | 0.138 mL | 0.276 mL | 0.6901 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
BZAD01 305339-41-7 Neuroscience NMDAR Inhibitor NR2B NMDA BZAD-01 iGluR Ionotropic glutamate receptors BZAD 01 inhibit inhibitor